Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Brenner

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Gastroenterology Clinics of North America|January 5, 2002
Prostaglandin inhibitors and the chemoprevention of noncolonic malignancyK Krishnan, D E Brenner
Gastroenterology Clinics of North America|December 1, 1996
Chemoprevention of colorectal cancerK Krishnan, D E Brenner
British Journal of Cancer|September 15, 2005
Cancer chemoprevention: lessons learned and future directionsD E Brenner, A J Gescher
Archives of Dermatology|November 1, 1977
Serratia marcescens cellulitisD E Brenner, D P Lookingbill
Lancet (London, England)|October 25, 1980
Anaerobic microorganisms in chronic suppurative hidradenitisD E Brenner, D P Lookingbill
Critical Reviews in Oncology/Hematology|May 2, 2000
Chemoprevention: general perspectiveI Shureiqi, P Reddy, D E Brenner
Hematology/Oncology Clinics of North America|January 15, 1999
Clinical models of chemoprevention for colon cancerK Krishnan, M T Ruffin, D E Brenner
Cancer Treatment Reports|March 1, 1981
Doxorubicin and dactinomycin therapy for advanced sarcomasD E Brenner, P Chang, P H Wiernik
Critical Reviews in Oncology/Hematology|May 2, 2000
Chemoprevention for colorectal cancerK Krishnan, M T Ruffin, D E Brenner
Anticancer Research|March 1, 1989
Cellular pharmacology of doxorubicinol alone and combined with verapamil in pancreatic cancer cell linesB K Chang, D E Brenner, R Gutman
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Gastroenterology Clinics of North America|January 5, 2002
Prostaglandin inhibitors and the chemoprevention of noncolonic malignancyK Krishnan, D E Brenner
Gastroenterology Clinics of North America|December 1, 1996
Chemoprevention of colorectal cancerK Krishnan, D E Brenner
British Journal of Cancer|September 15, 2005
Cancer chemoprevention: lessons learned and future directionsD E Brenner, A J Gescher
Archives of Dermatology|November 1, 1977
Serratia marcescens cellulitisD E Brenner, D P Lookingbill
Lancet (London, England)|October 25, 1980
Anaerobic microorganisms in chronic suppurative hidradenitisD E Brenner, D P Lookingbill
Critical Reviews in Oncology/Hematology|May 2, 2000
Chemoprevention: general perspectiveI Shureiqi, P Reddy, D E Brenner
Hematology/Oncology Clinics of North America|January 15, 1999
Clinical models of chemoprevention for colon cancerK Krishnan, M T Ruffin, D E Brenner
Cancer Treatment Reports|March 1, 1981
Doxorubicin and dactinomycin therapy for advanced sarcomasD E Brenner, P Chang, P H Wiernik
Critical Reviews in Oncology/Hematology|May 2, 2000
Chemoprevention for colorectal cancerK Krishnan, M T Ruffin, D E Brenner
Anticancer Research|March 1, 1989
Cellular pharmacology of doxorubicinol alone and combined with verapamil in pancreatic cancer cell linesB K Chang, D E Brenner, R Gutman
Pageof 9